ArticlePharmaceutics2022
Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease.
Vipul Yadav et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticlePharmaceutics2022
Vipul Yadav et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.